Dynavax to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference
EMERYVILLE, Calif., June 9, 2021 /PRNewswire/ -- Dynavax Technologies Corporation (Nasdaq: DVAX), a biopharmaceutical company focused on developing and commercializing novel vaccines, today announced that Ryan Spencer, Chief Executive Officer, will present virtually at the Goldman Sachs 42nd Annual Global Healthcare Conference on Thursday, June 10, 2021 at 3:50 p.m. E.T.
The presentation will be webcast and may be accessed through the "Events & Presentations" page on the "Investors" section of the Company's website at http://investors.dynavax.com/events-presentations.
Derek Cole, President
View original content to download multimedia:http://www.prnewswire.com/news-releases/dynavax-to-present-at-the-goldman-sachs-42nd-annual-global-healthcare-conference-301309437.html
SOURCE Dynavax Technologies
Company Codes: NASDAQ-SMALL:DVAX